Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2021

01-11-2021 | Endometrial Cancer | ASO Author Reflections

ASO Author Reflections: Malignant Peritoneal Cytology, Adjuvant Therapy Choice, and Survival in Advanced Endometrial Cancer

Authors: Shinya Matsuzaki, MD, PhD, Heather Miller, MD, Maximilian Klar, MD, MPH, Koji Matsuo, MD, PhD

Published in: Annals of Surgical Oncology | Issue 12/2021

Login to get access

Excerpt

Malignant peritoneal cytology refers to the presence of tumor cells in the peritoneal cytologic washing sample obtained at the time of hysterectomy-based surgical staging for endometrial cancer treatment. Malignant peritoneal cytology implies that the tumor cells of endometrial cancer have spread beyond the site of anatomic tumor origin, the uterine corpus. Previously, the survival effect of malignant peritoneal cytology and the implications for adjuvant therapy were understudied in advanced endometrial cancer. …
Literature
1.
2.
Matsuo K, Wright JD, Matsuzaki S, Roman LD, Harter P, Klar M. Malignant peritoneal cytology in endometrial cancer: areas of unmet need for evidence. Eur J Cancer. 2020;140:149–50.CrossRef
3.
4.
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef
5.
Matsuo K, Matsuzaki S, Roman LD, Klar M, Wright JD. Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology. Am J Obstet Gynecol. 2021;224:319–21.CrossRef
Metadata
Title
ASO Author Reflections: Malignant Peritoneal Cytology, Adjuvant Therapy Choice, and Survival in Advanced Endometrial Cancer
Authors
Shinya Matsuzaki, MD, PhD
Heather Miller, MD
Maximilian Klar, MD, MPH
Koji Matsuo, MD, PhD
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 12/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-09908-w

Other articles of this Issue 12/2021

Annals of Surgical Oncology 12/2021 Go to the issue

ASO Author Reflections

ASO Author Reflections: R0 Resection After Oncologic Esophagectomy—Cutting on the Edge (0 cm) is Not Enough

ASO Author Reflections

ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma

Breast Oncology

Development and Validation of an Intraoperative Nomogram to Predict Breast Cancer-Related Lymphedema Based on the Arm Lymphatics Distribution

Breast Oncology

High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer

Sarcoma

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

ASO Author Reflections

ASO Author Reflections: Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC